| Full Name | Peter Shih |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 26 Years |
| Location | 550 1st Ave, New York, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023006665 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0200X | Internal Medicine - Critical Care Medicine | 221384 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Fort Walton Beach Medical Center | Fort walton beach, FL | Hospital |
| Twin Cities Hospital | Niceville, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| White-wilson Medical Center Pa | 4082510607 | 79 |
News Archive
A Novartis Pharmaceuticals Corporation Phase III study of Afinitor® (everolimus) tablets in combination with Sandostatin® LAR Depot (octreotide acetate for injectable suspension) extended median progression-free survival (PFS), or time without tumor growth, in patients with advanced carcinoid tumors compared to taking octreotide LAR alone.
Tonight, in a partisan vote, the U.S. Senate voted to proceed to Senator Reid's version of the government takeover of health care. Among the several objectionable items included in this bill; like the public option, employer and individual mandates, is the government funding for elective abortion, which is the most onerous and morally objectionable.
Using advanced mass spectrometry technology, scientists from the Florida campus of The Scripps Research Institute have developed a molecular model that may provide a new framework for improving the design of osteoporosis treatments.
Abbott announced today that the first patient in Japan has been treated with the ABSORB bioresorbable vascular scaffold (BVS) as part of the ABSORB EXTEND clinical trial.
› Verified 4 days ago
| Entity Name | White-wilson Medical Center Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467437277 PECOS PAC ID: 4082510607 Enrollment ID: O20031212000140 |
News Archive
A Novartis Pharmaceuticals Corporation Phase III study of Afinitor® (everolimus) tablets in combination with Sandostatin® LAR Depot (octreotide acetate for injectable suspension) extended median progression-free survival (PFS), or time without tumor growth, in patients with advanced carcinoid tumors compared to taking octreotide LAR alone.
Tonight, in a partisan vote, the U.S. Senate voted to proceed to Senator Reid's version of the government takeover of health care. Among the several objectionable items included in this bill; like the public option, employer and individual mandates, is the government funding for elective abortion, which is the most onerous and morally objectionable.
Using advanced mass spectrometry technology, scientists from the Florida campus of The Scripps Research Institute have developed a molecular model that may provide a new framework for improving the design of osteoporosis treatments.
Abbott announced today that the first patient in Japan has been treated with the ABSORB bioresorbable vascular scaffold (BVS) as part of the ABSORB EXTEND clinical trial.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Peter Shih, MD 550 1st Ave, New York, NY 10016-6402 Ph: (212) 867-9850 | Peter Shih, MD 550 1st Ave, New York, NY 10016-6402 Ph: (212) 867-9850 |
News Archive
A Novartis Pharmaceuticals Corporation Phase III study of Afinitor® (everolimus) tablets in combination with Sandostatin® LAR Depot (octreotide acetate for injectable suspension) extended median progression-free survival (PFS), or time without tumor growth, in patients with advanced carcinoid tumors compared to taking octreotide LAR alone.
Tonight, in a partisan vote, the U.S. Senate voted to proceed to Senator Reid's version of the government takeover of health care. Among the several objectionable items included in this bill; like the public option, employer and individual mandates, is the government funding for elective abortion, which is the most onerous and morally objectionable.
Using advanced mass spectrometry technology, scientists from the Florida campus of The Scripps Research Institute have developed a molecular model that may provide a new framework for improving the design of osteoporosis treatments.
Abbott announced today that the first patient in Japan has been treated with the ABSORB bioresorbable vascular scaffold (BVS) as part of the ABSORB EXTEND clinical trial.
› Verified 4 days ago
Dr. Ravishankar Ramaswamy, MD, MS Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1440 Madison Avenue, New York, NY 10029 Phone: 212-659-8552 Fax: 212-860-9737 | |
Dr. Pietro Alessandro Ambrogio Canetta, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 622 W 168th St, Ph4-124, New York, NY 10032 Phone: 212-305-5020 Fax: 212-305-6692 | |
Dr. Rakhshan Mahmood Chida, M.D. Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 327 E 17th St, New York, NY 10003 Phone: 212-420-5690 | |
Charles D Resor, Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 622 W 168th St, New York, NY 10032 Phone: 212-305-2913 | |
Dr. Jacqueline Yuey Lonier, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1150 Saint Nicholas Ave, New York, NY 10032 Phone: 212-851-5494 | |
Dr. Sharon Uralil, D.O. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 550 1st Ave, New York, NY 10016 Phone: 212-263-3293 | |
Diana Kantor, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 775 9th Ave, New York, NY 10019 Phone: 212-586-1550 |